Mali - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
Since 2014, Mali Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases was up 26.6% year on year. In 2019, the country was ranked number 125 among other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases at 130 Cases. Mali is overtaken by United States, which was ranked number 124 with 131 Cases and is followed by Iraq with 129 Cases. India lead the ranking with 66,255 Cases in 2019, an increase of 13.6% compared to 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo witnessed the best average annual growth at +171.1% per year, while Croatia witnessed the worst performance at -100% per year.
Loading...
| Date | Units (Cases) |
|---|---|
| 2019 | 130.00 |
| 2018 | 123.00 |
| 2017 | 34.00 |
| 2016 | 386.00 |
| 2015 | 31.00 |
How does Mali rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
| # | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data | |
| 3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data | |
| 124 |
#124
United States
|
131 | 2019 | -0.8 % | +3.9 % | View data | |
| 125 |
#125
Mali
|
130 | 2019 | +5.7 % | +26.6 % | View data | |
| 126 |
#126
Iraq
|
129 | 2019 | +2.4 % | -8.0 % | View data | |